Nexus AG (LON:0FGL)
71.40
0.00 (0.00%)
At close: Aug 29, 2025
Nexus AG Revenue
Nexus AG had revenue of 71.75M EUR in the quarter ending June 30, 2025, with 9.10% growth. This brings the company's revenue in the last twelve months to 278.55M, up 6.57% year-over-year. In the year 2024, Nexus AG had annual revenue of 265.52M with 8.27% growth.
Revenue (ttm)
278.55M EUR
Revenue Growth
+6.57%
P/S Ratio
4.44
Revenue / Employee
145.91K EUR
Employees
1,909
Market Cap
1.06B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 265.52M | 20.28M | 8.27% |
Dec 31, 2023 | 245.24M | 33.73M | 15.95% |
Dec 31, 2022 | 211.51M | 20.80M | 10.91% |
Dec 31, 2021 | 190.71M | 24.75M | 14.91% |
Dec 31, 2020 | 165.96M | 14.46M | 9.54% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Oxford Nanopore Technologies | 183.19M |